INTENSIVE INDUCTION CHEMOTHERAPY FOR POOR RISK NON-SEMINOMATOUS GERM-CELL TUMORS

被引:71
作者
HORWICH, A [1 ]
BRADA, M [1 ]
NICHOLLS, J [1 ]
JAY, G [1 ]
HENDRY, WF [1 ]
DEARNALEY, D [1 ]
PECKHAM, MJ [1 ]
机构
[1] INST CANC RES,SUTTON SM2 5PX,SURREY,ENGLAND
来源
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1989年 / 25卷 / 02期
关键词
D O I
10.1016/0277-5379(89)90005-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:177 / 184
页数:8
相关论文
共 31 条
[1]   PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS [J].
BIRCH, R ;
WILLIAMS, S ;
CONE, A ;
EINHORN, L ;
ROARK, P ;
TURNER, S ;
GRECO, FA .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) :400-407
[2]   VAB-6 - AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH GERM-CELL TUMORS [J].
BOSL, GJ ;
GLUCKMAN, R ;
GELLER, NL ;
GOLBEY, RB ;
WHITMORE, WF ;
HERR, H ;
SOGANI, P ;
MORSE, M ;
MARTINI, N ;
BAINS, M ;
MCCORMACK, P .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1493-1499
[3]   ALTERNATING CYCLES OF ETOPOSIDE PLUS CISPLATIN AND VAB-6 IN THE TREATMENT OF POOR-RISK PATIENTS WITH GERM-CELL TUMORS [J].
BOSL, GJ ;
GELLER, NL ;
VOGELZANG, NJ ;
CAREY, R ;
AUMAN, J ;
WHITMORE, WF ;
HERR, H ;
MORSE, M ;
SOGANI, P ;
CHAN, E .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :436-440
[4]   HIGH-DOSE CISPLATIN AND VP-16 WITH BLEOMYCIN, IN THE MANAGEMENT OF ADVANCED METASTATIC GERM-CELL TUMORS [J].
DAUGAARD, G ;
RORTH, M .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (04) :477-485
[5]   HAVE NEW AGGRESSIVE CHEMOTHERAPY REGIMENS IMPROVED RESULTS IN ADVANCED GERM-CELL TUMORS [J].
EINHORN, LH .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (11) :1289-1293
[6]  
EINHORN LH, 1977, ANN INTERN MED, V87, P292
[7]   TUMOR-MARKER LEVELS AND PROGNOSIS IN MALIGNANT TERATOMA OF THE TESTIS [J].
GERMALLUCH, JR ;
BEGENT, RHJ ;
BAGSHAWE, KD .
BRITISH JOURNAL OF CANCER, 1980, 42 (06) :850-855
[8]   PROGNOSIS FOLLOWING CHEMOTHERAPY FOR METASTATIC MALIGNANT TERATOMA [J].
HORWICH, A ;
EASTON, D ;
HUSBAND, J ;
NICHOLAS, D ;
PECKHAM, MJ .
BRITISH JOURNAL OF UROLOGY, 1987, 59 (06) :578-583
[9]  
HORWICH A, 1986, CANCER TREAT REP, V70, P1329
[10]  
LEVI J, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P97